Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OTLK Outlook Therapeutics, Inc.

交易中 07-22 09:30:39 EDT

7.93

-0.03

-0.38%

最高7.93	最低7.93	成交量2,466
今开7.93	昨收7.96	日振幅0.00%
总市值1.86亿	流通市值9,508万	总股本2,341万
成交额1.96万	换手率0.02%	流通股本1,199万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OTLK","market":"US","secType":"STK","nameCN":"Outlook Therapeutics, Inc.","latestPrice":7.93,"timestamp":1721655016778,"preClose":7.96,"halted":0,"volume":2466,"delay":0,"floatShares":11989696,"shares":23405637,"eps":-11.982052,"marketStatus":"交易中","marketStatusCode":2,"change":-0.03,"latestTime":"07-22 09:30:39 EDT","open":7.93,"high":7.93,"low":7.93,"amount":19556.60067,"amplitude":0,"askPrice":8.1,"askSize":700,"bidPrice":7.81,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-11.982052,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"adjPreClose":7.96,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.96,"preClose":7.96,"latestTime":"08:27 EDT","volume":5,"amount":39.8,"timestamp":1721651223045},"postHourTrading":{"tag":"盘后","latestPrice":7.96,"preClose":7.96,"latestTime":"19:21 EDT","volume":71,"amount":564.36,"timestamp":1721431315832},"volumeRatio":4.317599,"impliedVol":0.0838,"impliedVolPercentile":0.0455},"requestUrl":"/m/hq/s/OTLK","defaultTab":"news","newsList":[{"id":"2452438163","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.03%报8.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452438163","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452438163?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:53","pubTimestamp":1721314381,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时53分，Outlook Therapeutics, Inc.股票出现异动，股价快速下跌5.03%。截至发稿，该股报8.50美元/股，成交量5.4418万股，换手率0.23%，振幅6.48%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Silo Pharma, Inc.、Onconetix, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1979.77%、1046.65%、156.40%，振幅较大的相关个股有Silo Pharma, Inc.、Onconetix, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 ，振幅分别为93.33%、86.24%、65.64%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718225301941f85be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718225301941f85be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2451165469","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451165469","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451165469?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:37","pubTimestamp":1721140622,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日22时37分，Outlook Therapeutics, Inc.股票出现异动，股价快速拉升5.09%。截至发稿，该股报8.88美元/股，成交量5.8873万股，换手率0.25%，振幅3.91%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2000.82%、1162.94%、288.72%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为61.68%、47.79%、44.12%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716223702af929b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716223702af929b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2451091550","title":"Outlook Therapeutics, Inc.盘中异动 临近收盘股价大涨5.01%报8.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451091550","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451091550?lang=zh_cn&edition=full","pubTime":"2024-07-13 03:43","pubTimestamp":1720813390,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日03时43分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报8.80美元/股，成交量16.775万股，换手率0.72%，振幅6.44%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Qualigen Therapeutics, Inc.、Soligenix, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为4172.15%、126.06%、104.16%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Xortx Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为147.88%、78.88%、65.30%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713034310aef98042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713034310aef98042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2450475968","title":"Outlook Therapeutics, Inc.盘中异动 快速跳水5.19%报7.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450475968","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450475968?lang=zh_cn&edition=full","pubTime":"2024-07-11 03:40","pubTimestamp":1720640443,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日03时40分，Outlook Therapeutics, Inc.股票出现异动，股价急速下跌5.19%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至03时40分，《BTIG维持Outlook Therapeutics买入评级，维持目标价50美元》资讯为影响Outlook Therapeutics, Inc.的重要信息。该信息摘要如下：BTIG分析师Julian Harrison维持$Outlook Therapeutics $买入评级，维持目标价50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711034044af91a381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711034044af91a381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2449090567","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速上涨5.05%报7.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449090567","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449090567?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:35","pubTimestamp":1720449344,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时35分，Outlook Therapeutics, Inc.股票出现波动，股价大幅上涨5.05%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Virpax Pharmaceuticals, Inc.、Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为2089.69%、171.77%、139.71%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Cero Therapeutics Holdings, Inc.，振幅分别为93.43%、46.35%、36.60%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708223544aef87ae9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708223544aef87ae9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2438512377","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438512377","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438512377?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:44","pubTimestamp":1716903842,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时44分，Outlook Therapeutics, Inc.股票出现波动，股价快速跳水5.06%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Exicure, Inc.涨幅较大，Exicure, Inc.、Jaguar Health, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为33.73%、9.31%、7.62%，振幅较大的相关个股有Exicure, Inc.、Insmed Incorporated、Renovaro Inc.，振幅分别为70.52%、20.32%、19.72%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。该信息摘要如下：Outlook Therapeutics Inc——与Cencora建立战略合作伙伴关系以支持Lytenava计划在欧盟商业上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528214403af8ab37f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528214403af8ab37f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2438344376","title":"Outlook Therapeutics Inc——与Cencora（前身为Amerisourcebergen）建立战略合作伙伴关系以支持Lytenava计划在欧盟商业上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2438344376","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438344376?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:17","pubTimestamp":1716898622,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics Inc——与Cencora（前身为Amerisourcebergen）建立战略合作伙伴关系以支持Lytenava计划在欧盟商业上市","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528201704956ec7b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528201704956ec7b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004303.SGD","OTLK","LU1261432733.SGD","BK4084","LENZ","LU1585245621.USD","BK4529","BK4139","BK4175","SGXZ23171101.USD","BK4585","BK4588","LU1430594728.SGD","COR"],"gpt_icon":0},{"id":"2438037588","title":"Outlook Therapeutics 获得欧盟委员会用于治疗湿性 AMD 的 Lytenava（贝伐珠单抗 Gamma）的上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2438037588","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438037588?lang=zh_cn&edition=full","pubTime":"2024-05-28 20:16","pubTimestamp":1716898599,"startTime":"0","endTime":"0","summary":"Outlook Therapeutics 获得欧盟委员会用于治疗湿性 AMD 的 Lytenava（贝伐珠单抗 Gamma）的上市许可","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282016439ef94ad4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405282016439ef94ad4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0642271901.SGD","LU1064131342.USD","BK4588","BK4532","BK4566","IE00BMPRXR70.SGD","IE0004445239.USD","BK4139","IE0009356076.USD","LU0719512351.SGD","AMD","LU1989764664.SGD","LU2458330243.SGD","LU1242518931.SGD","LU1803068979.SGD","LU1923623000.USD","LU1988902786.USD","BK4141","GFS","LU0127658192.USD","LU1852331112.SGD","BK4554","LU0109392836.USD","LU1951198990.SGD","LU0082616367.USD","OTLK","BK4573","BK4534","LU0056508442.USD","LU2264538146.SGD","LU0198837287.USD","BK4512","LU0979878070.USD","LU1316542783.SGD","LU2458330169.SGD","BK4575","BK4585","LU1951200564.SGD","BK4529","LU2098885051.SGD","LU0889565833.HKD","LENZ","IE00BMPRXN33.USD","LU1242518857.USD","LU1303367103.USD"],"gpt_icon":0},{"id":"2436333193","title":"Outlook Therapeutics, Inc.2024财年第一财季实现净利润-1.14亿美元，同比减少1614.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436333193","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436333193?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:20","pubTimestamp":1716135612,"startTime":"0","endTime":"0","summary":"3月31日，Outlook Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-1.14亿美元，同比减少1614.29%；其中营业收入为0.00美元，每股基本收益为-8.01美元。从资产负债表来看，Outlook Therapeutics, Inc.总负债1.93亿美元，其中短期债务44.75百万美元，资产负债比为30.59，流动比率为1.07。机构评级：截至2024年3月31日，当前有7家机构对Outlook Therapeutics, Inc.目标价做出预测，其中目标均价为38.86美元，其中最低目标价为25.00美元，最高目标价为53.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200020228b186af2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405200020228b186af2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ"],"gpt_icon":0},{"id":"2435197265","title":"Outlook Therapeutics Inc   预计每股亏损85美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2435197265","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435197265?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:53","pubTimestamp":1715694790,"startTime":"0","endTime":"0","summary":"   * Outlook Therapeutics Inc    将于5月16日公布截至0001年1月1日的财报，预计该公司的季度收入将没有变化。*    * LSEG的分析师平均预计Outlook Therapeutics Inc每股亏损85美分。* 华尔街对 Outlook Therapeutics Inc 的 12 个月目标价中位数为 38.00 美元，高于其最新收盘价 7.54 美元。5月14日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","OTLK"],"gpt_icon":0},{"id":"2435766613","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报7.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435766613","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435766613?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:08","pubTimestamp":1715609308,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时08分，Outlook Therapeutics, Inc.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报7.97美元/股，成交量3.475万股，换手率0.15%，振幅4.88%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.06%、27.16%、19.11%，振幅较大的相关个股有Dbv Technologies、Tevogen Bio Holdings Inc.、Azitra Inc，振幅分别为36.84%、35.55%、29.77%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132208297a599c0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132208297a599c0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2431686641","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨6.05%报8.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431686641","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431686641?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:50","pubTimestamp":1714398618,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时50分，Outlook Therapeutics, Inc.股票出现异动，股价急速拉升6.05%。截至发稿，该股报8.94美元/股，成交量1.2681万股，换手率0.05%，振幅5.10%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Immunitybio, Inc.、Moolec Science Sa C/Wts 、Soleno Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为673.60%、29.79%、14.92%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Immunitybio, Inc.、Enlivex Therapeutics Ltd.，振幅分别为33.33%、29.01%、22.22%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292150197924ee64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292150197924ee64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2428340951","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428340951","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428340951?lang=zh_cn&edition=full","pubTime":"2024-04-17 23:03","pubTimestamp":1713366235,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日23时03分，Outlook Therapeutics, Inc.股票出现波动，股价快速上涨5.14%。截至发稿，该股报9.20美元/股，成交量7.3888万股，换手率0.33%，振幅4.33%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为136.65%、37.64%、37.00%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Dare Bioscience, Inc.，振幅分别为80.94%、48.51%、41.02%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723035579214569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041723035579214569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2426977804","title":"Outlook Therapeutics, Inc.盘中异动 早盘快速下跌5.51%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426977804","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426977804?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:55","pubTimestamp":1712757327,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时55分，Outlook Therapeutics, Inc.股票出现波动，股价大幅下挫5.51%。截至发稿，该股报8.75美元/股，成交量5.4482万股，换手率0.25%，振幅2.81%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Adial Pharmaceuticals, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为1382.44%、71.17%、28.79%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Calidi Biotherapeutics, Inc.、Silo Pharma, Inc.，振幅分别为62.83%、31.96%、24.26%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021552787e7f4e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021552787e7f4e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2426112785","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426112785","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426112785?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:01","pubTimestamp":1712678516,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日00时01分，Outlook Therapeutics, Inc.股票出现波动，股价快速上涨5.45%。截至发稿，该股报9.86美元/股，成交量15.6261万股，换手率0.72%，振幅4.60%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Acrivon Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 、Syros Pharmaceuticals, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为469.19%、110.41%、97.58%，振幅较大的相关个股有Mymd Pharmaceuticals, Inc.、Biophytis、Cadrenal Therapeutics, Inc.，振幅分别为50.11%、40.61%、39.14%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041000015687e7eea4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041000015687e7eea4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2424846776","title":"Outlook Therapeutics, Inc.盘中异动 急速上涨5.26%报10.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424846776","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424846776?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:36","pubTimestamp":1712151395,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时36分，Outlook Therapeutics, Inc.股票出现异动，股价大幅上涨5.26%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Kintara Therapeutics, Inc.、方舟生物医药、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Kintara Therapeutics, Inc.、方舟生物医药、Addex Therapeutics Limited较为活跃，换手率分别为268.17%、90.14%、16.54%，振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、Tracon Pharmaceuticals, Inc.，振幅分别为29.88%、23.39%、22.04%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032136357a50f897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032136357a50f897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2422194793","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422194793","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422194793?lang=zh_cn&edition=full","pubTime":"2024-03-28 21:36","pubTimestamp":1711632976,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日21时36分，Outlook Therapeutics, Inc.股票出现异动，股价急速上涨5.02%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Nutriband Inc C/Wts 涨幅较大，Avalo Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Ibio, Inc.较为活跃，换手率分别为462.57%、371.82%、365.81%，振幅较大的相关个股有Avalo Therapeutics, Inc.、Nutriband Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为71.16%、41.04%、31.00%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。消息层面，截至21时36分，Outlook Therapeutics, Inc.股票正面舆情新闻比例20%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213617791d9d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328213617791d9d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2422997664","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大涨7.72%报9.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422997664","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422997664?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:32","pubTimestamp":1711546334,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时32分，Outlook Therapeutics, Inc.股票出现波动，股价急速上涨7.72%。截至发稿，该股报9.35美元/股，成交量13.4246万股，换手率0.62%，振幅1.84%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Hoth Therapeutics, Inc.较为活跃，换手率分别为873.43%、388.79%、48.71%，振幅较大的相关个股有Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Annexon, Inc.，振幅分别为32.17%、19.73%、15.19%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272132158b69daa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272132158b69daa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2422060510","title":"Outlook Therapeutics, Inc.盘中异动 大幅下挫5.21%报8.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422060510","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422060510?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:34","pubTimestamp":1711373670,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时34分，Outlook Therapeutics, Inc.股票出现异动，股价快速下挫5.21%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1007.97%、47.61%、31.25%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Matinas Biopharma Holdings, Inc.，振幅分别为21.97%、19.84%、11.69%。Outlook Therapeutics, Inc.公司简介：Oncobiologics Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213430791cacde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325213430791cacde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2421812888","title":"BUZZ-Outlook Therapeutics公司因欧盟药品监管机构支持其眼病药物而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2421812888","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421812888?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:09","pubTimestamp":1711116545,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月22日 - ** Outlook Therapeutics   股价上涨35.6%至9.58美元** 该公司称， (link)，欧盟药品监管机构已建议批准OTLK治疗一种名为湿性老年性黄斑变性的眼病的药物(wet AMD)** 预计欧盟委员会将在药物监管机构提出意见后的 67 天内做出批准决定。** 湿性黄斑变性是一种眼底血管异常生长的疾病，会导致视力下降** 过去 12 个月股价下跌 53","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OTLK","BUZZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.outlooktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0934},{"period":"1month","weight":0.1259},{"period":"3month","weight":-0.0257},{"period":"6month","weight":0.1404},{"period":"1year","weight":-0.7631},{"period":"ytd","weight":0.0102}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Outlook Therapeutics, Inc.于2010年1月5日在新泽西州注册成立。该公司是一家临床晚期生物制药公司，致力于开发首个经美国食品和药物管理局（FDA）批准用于视网膜适应症的贝伐单抗眼科制剂。他们直接或通过战略合作伙伴推出贝伐单抗，作为美国、英国、欧洲、日本等市场首个也是唯一批准的贝伐单抗，用于治疗湿性老年性黄斑变性、湿性AMD、糖尿病性黄斑水肿（DME）和视网膜分支静脉阻塞，他们正在就ONS-5010的许可和共同开发权进行积极的后期讨论。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.120556},{"month":2,"riseRate":0.5,"avgChangeRate":0.214631},{"month":3,"riseRate":0.375,"avgChangeRate":-0.032392},{"month":4,"riseRate":0.375,"avgChangeRate":-0.151083},{"month":5,"riseRate":0.625,"avgChangeRate":0.151955},{"month":6,"riseRate":0.375,"avgChangeRate":-0.036511},{"month":7,"riseRate":0.555556,"avgChangeRate":0.024966},{"month":8,"riseRate":0.375,"avgChangeRate":-0.146061},{"month":9,"riseRate":0.5,"avgChangeRate":0.064501},{"month":10,"riseRate":0.375,"avgChangeRate":0.187824},{"month":11,"riseRate":0.125,"avgChangeRate":-0.10027},{"month":12,"riseRate":0.375,"avgChangeRate":-0.109516}],"exchange":"NASDAQ","name":"Outlook Therapeutics, Inc.","nameEN":"Outlook Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Outlook Therapeutics, Inc.,OTLK,Outlook Therapeutics, Inc.股票,Outlook Therapeutics, Inc.股票老虎,Outlook Therapeutics, Inc.股票老虎国际,Outlook Therapeutics, Inc.行情,Outlook Therapeutics, Inc.股票行情,Outlook Therapeutics, Inc.股价,Outlook Therapeutics, Inc.股市,Outlook Therapeutics, Inc.股票价格,Outlook Therapeutics, Inc.股票交易,Outlook Therapeutics, Inc.股票购买,Outlook Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}